![]() |
市場調查報告書
商品編碼
1828098
2025年全球支氣管鏡市場報告Bronchoscope Global Market Report 2025 |
近年來,支氣管鏡市場呈現強勁成長勢頭,市場規模從2024年的29.5億美元成長至2025年的32億美元,複合年成長率達8.8%。預測期內的成長可歸因於認知度和接受度的提升、醫學訓練和教育、臨床應用和支氣管內介入治療的開展、對微創技術的需求以及人口老化。
預計未來幾年支氣管鏡市場將快速成長,到2029年將達到49.7億美元,複合年成長率為11.6%。預測期內的成長動力包括呼吸系統疾病的增加、人口老化、對微創手術的需求、機器人技術的進步以及對早期診斷的重視。預測期內的主要趨勢包括小型化和便攜性、對患者安全和舒適度的重視、擴增實境(AR) 和導航系統、遠端醫療和遠端引導以及一次性支氣管鏡。
支氣管鏡是用於目視檢查肺部和氣道的重要醫療設備。它由一根軟性或剛性的管子組成,管端裝有攝影機和光源,方便醫生觀察氣管、支氣管和支氣管導管。支氣管鏡既可用於診斷,也可用於治療,有助於組織切片檢查、去除異物以及各種氣道醫療干預等操作。
支氣管鏡主要有兩種類型:硬式和軟式。硬式支氣管鏡由金屬製成,由手柄、管和鞘套組成。它們用於診斷和治療呼吸系統疾病,並可用於異物取出、腫瘤切除、支架置入、切片檢查、止血和雷射治療等操作。支氣管鏡有可重複使用和一次性兩種類型,以滿足醫院、診所、門診手術中心和類似醫療機構的診斷和治療需求。
2025年春季,美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響,尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要重新認證醫療設備,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供支氣管鏡市場統計數據,例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的支氣管鏡細分市場、市場趨勢和機遇,以及您在支氣管鏡行業取得成功所需的數據。本支氣管鏡市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
未來五年的預測成長率為11.6%,較我們先前對該市場的預測略有下降0.2%。下降的主要原因是美國與其他國家之間關稅的影響。這種影響可能會直接波及美國,導致來自德國和日本等主要地區的光纖影像處理束和關節控制機制的供應鏈中斷,從而導致肺部手術延誤和設備維護成本增加。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,這種影響也將更加廣泛。
呼吸系統疾病的日益普及預計將推動未來支氣管鏡市場的成長。呼吸系統疾病是指影響呼吸系統的疾病,例如氣喘、慢性阻塞性肺病(COPD)、肺炎、支氣管炎、囊腫纖維化、肺纖維化和肺癌。由於支氣管鏡檢查是一種診斷和治療工具,能夠評估和治療各種呼吸系統疾病,因此這些疾病的發生率上升可能會導致對支氣管鏡的需求增加。例如,根據澳洲政府機構澳洲健康與福利研究所 (AIHW) 2024 年 6 月發布的報告,到 2023 年,慢性阻塞性肺病 (COPD) 將佔總疾病負擔的 3.6%,佔呼吸系統疾病負擔的 50%。此外,據報道,2022 年 87% 的 COPD 患者將患有一種或多種合併症,其中最常見的是精神/行為問題(49%)、關節炎(45%)、氣喘和背部問題(各 42%)。因此,呼吸系統疾病盛行率的上升預計將增強支氣管鏡市場。
預計未來對微創手術的需求將推動支氣管鏡市場的成長。微創手術 (MIP) 是透過體內小切口進行的外科手術。微創支氣管鏡檢查具有多種優勢,包括侵入性降低、患者偏好、診斷和治療方法的進步、恢復時間更短以及併發症率更低。軟性支氣管鏡和視訊支氣管鏡等先進儀器的發展提高了這些手術的準確性和有效性。例如,2023 年 9 月,美國美容整形外科醫師協會 (ISAPS) 報告稱,2022 年整形外科醫生執行的手術數量將增加 11.2%,全球整體外科手術超過 1490 萬例,非外科手術超過 1880 萬例。因此,對微創手術的不斷成長的需求正在推動支氣管鏡市場的成長。
支氣管鏡市場的主要企業正在開發細直徑支氣管鏡等創新產品,以提高患者舒適度、增強遠端氣道的可及性並最佳化微創手術中的診斷和治療能力。細直徑支氣管鏡採用窄型設計,方便進入小氣道並提高患者在手術過程中的舒適度。例如,2024 年 5 月,日本醫療技術和光學公司奧林巴斯株式會社推出了與 EVIS X1 內視鏡系統相容的支氣管鏡。 BF-H1100 和 BF-1TH1100 支氣管鏡具有高清影像和細直徑,可改善遠端氣道的可及性。 BF-H1100 具有 2.2 毫米工作通道,吸力提高 11%,而 BF-1TH1100 具有 3.0 毫米工作通道,吸力提高 29%。兩款型號均採用重新設計的影像感測器,以實現高清電視解析度,並結合了 BAI-MAC、TXI、RDI 和 NBI 等先進成像技術,以提高支氣管鏡檢查過程中的診斷準確性。
支氣管鏡市場的主要企業正致力於開發具有即時影像處理功能的先進機器人技術,以提高診斷準確性、減輕患者不適感並縮短肺部疾病診療過程中的恢復時間。具有即時成像功能的先進機器人技術包括利用即時成像技術即時引導精確操作和決策的機器人系統。例如,2024年9月,美國醫療保健供應商TidalHealth Nanticoke推出了一款基於Ion平台的先進機器人支氣管鏡系統,以增強肺部疾病的診斷和治療。這項最尖端科技為微創肺組織切片檢查提供了高清視覺化和精確度,使專家能夠更有效地導航複雜的支氣管通道。
2022年5月,總部位於愛爾蘭的知名醫療設備公司Medtronic)完成了對Intersect ENT的收購,收購金額未揭露。此策略措施整合了Intersect ENT的創新鼻竇植入產品,包括PROPEL和SINUVA,顯著擴展了Medtronic力在耳鼻喉(ENT)領域的產品組合。這些新增產品增強了Medtronic為慢性鼻竇炎(CRS)患者提供更全面護理的能力,並鞏固了其在全球醫療技術市場的地位。 Intersect ENT是一家美國醫療設備製造商,專門開發用於耳鼻喉(ENT)疾病的給藥裝置。
支氣管鏡市場的主要企業包括 Ambu A/S、波士頓科學公司、Cogentix Medical Inc.、Cook Medical LLC、富士膠片控股公司、Hoya Corporation、Karl Storz Endoscopy SE & Co.KG、奧林巴斯公司、PENTAX Medical、Richard Wolf GmbH、Teleflex Incorporchinated、EFpieER GmbH、Uptake Medical BV、Broncus Medical Inc.、Novatech SA、上海奧華光電內視鏡有限公司、Rochling Group、Stryker Corporation、NeoScope Inc.、Bryan Corporation、CONMED Corporation、Laborie Medical Technologies Corp.、Envision Endoscopy Inc.、SonoScape Medical Corp.、Vertronon Inc. 和 Medtronic plc。
2024年,北美是支氣管鏡市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。支氣管鏡市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。
支氣管鏡市場報告涵蓋的國家:澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙
支氣管鏡市場包括光纖支氣管鏡和視訊支氣管鏡的銷售。該市場的價值為“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。
A bronchoscope is a vital medical instrument employed to visually examine the lungs and airways. It comprises a flexible or rigid tube equipped with a camera and light source at its tip, enabling physicians to observe the trachea, bronchi, and bronchioles. This device serves both diagnostic and therapeutic purposes, facilitating procedures such as tissue biopsy, foreign object removal, and various airway medical interventions.
Two primary variants of bronchoscopes exist, rigid and flexible. Rigid bronchoscopes, crafted from metal and composed of handles, tubes, and sheaths, find application in diagnosing and treating respiratory conditions. They are instrumental in procedures including foreign body extraction, tumor excision, stent insertion, biopsy, hemostasis, and laser therapy. Bronchoscopes come in reusable and disposable forms, catering to diagnostic and treatment needs across hospital settings, clinics, ambulatory surgical centers, and similar medical facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The bronchoscope market research report is one of a series of new reports from The Business Research Company that provides bronchoscope market statistics, including bronchoscope industry global market size, regional shares, competitors with a bronchoscope market share, detailed bronchoscope market segments, market trends and opportunities, and any further data you may need to thrive in the bronchoscope industry. This bronchoscope market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bronchoscope market size has grown strongly in recent years. It will grow from $2.95 billion in 2024 to $3.2 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing awareness and acceptance, medical training and education, clinical applications and endobronchial interventions, demand for minimally invasive techniques, aging population dynamics.
The bronchoscope market size is expected to see rapid growth in the next few years. It will grow to $4.97 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to rising respiratory disorders, growing aging population, demand for minimally invasive procedures, advancements in robotics, focus on early diagnosis. Major trends in the forecast period include miniaturization and portability, focus on patient safety and comfort, augmented reality (AR) and navigation systems, telemedicine and remote guidance, disposable bronchoscopes.
The forecast of 11.6% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for fiberoptic imaging bundles and articulating control mechanisms, sourced from key regions such as Germany and Japan, which could lead to delayed pulmonary procedures and increased equipment maintenance costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of respiratory tract disorders is expected to drive the growth of the bronchoscope market in the future. Respiratory tract disorders are medical conditions that impact the respiratory system, including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, bronchitis, cystic fibrosis, pulmonary fibrosis, and lung cancer. Bronchoscopy serves as a diagnostic and therapeutic tool that can evaluate and treat various respiratory tract disorders; therefore, the rise in these conditions is likely to lead to increased demand for bronchoscopes. For instance, in June 2024, a report from the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, stated that in 2023, COPD accounted for 3.6% of the total disease burden and 50% of the burden from respiratory conditions. Additionally, it was reported that 87% of COPD patients in 2022 had one or more comorbidities, with the most prevalent being mental and behavioral conditions (49%), arthritis (45%), and asthma and back problems (42% each). Therefore, the rise in the prevalence of respiratory tract disorders is anticipated to enhance the bronchoscope market.
The growing demand for minimally invasive procedures is expected to drive the growth of the bronchoscope market in the future. Minimally invasive procedures (MIPs) are surgical interventions conducted through small incisions in the body. Minimally invasive bronchoscopy provides several advantages, including reduced invasiveness, patient preference, advancements in diagnostics and therapeutics, faster recovery times, and lower complication rates. The development of advanced instruments, such as flexible and video bronchoscopes, enhances the precision and effectiveness of these procedures. For example, in September 2023, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization for board-certified aesthetic plastic surgeons, reported an 11.2% increase in procedures performed by plastic surgeons in 2022, with over 14.9 million surgical and 18.8 million non-surgical procedures carried out globally. Thus, the rising demand for minimally invasive procedures is driving the growth of the bronchoscope market.
Major companies in the bronchoscope market are developing innovative products, such as slim outer diameter bronchoscopes, to improve patient comfort, enhance access to distal airways, and optimize diagnostic and therapeutic capabilities in minimally invasive procedures. Slim bronchoscopes feature a narrow design that facilitates easier access to smaller airways and increases patient comfort during procedures. For example, in May 2024, Olympus Corporation, a Japan-based medical technology and optics company, launched bronchoscopes compatible with the EVIS X1 endoscopy system. The BF-H1100 and BF-1TH1100 bronchoscopes are equipped with high-definition imaging and a slim outer diameter to improve access to distal airways. The BF-H1100 includes a 2.2mm working channel, providing an 11% increase in suction, while the BF-1TH1100 has a 3.0mm working channel with a 29% suction increase. Both models feature a redesigned image sensor for HDTV resolution and incorporate advanced imaging technologies, such as BAI-MAC, TXI, RDI, and NBI, which enhance diagnostic accuracy in bronchoscopic procedures.
Major companies in the bronchoscope market are concentrating on developing advanced robotics with real-time imaging to improve diagnostic accuracy, reduce patient discomfort, and shorten recovery times during lung disease diagnosis and treatment. Advanced robotics with real-time imaging involves robotic systems that utilize live imaging technologies to guide precise actions and decision-making in real-time. For example, in September 2024, TidalHealth Nanticoke, a US-based healthcare organization, launched an advanced robotic bronchoscopy system using the Ion platform to enhance the diagnosis and treatment of lung diseases. This cutting-edge technology offers high-definition visualization and precision for less invasive lung tissue biopsies, allowing specialists to navigate complex bronchial passages more effectively.
In May 2022, Medtronic plc, an esteemed medical devices company based in Ireland, completed the acquisition of Intersect ENT for an undisclosed sum. This strategic move significantly broadened Medtronic's portfolio within the ear, nose, and throat (ENT) segment by integrating innovative sinus implant products such as PROPEL and SINUVA from Intersect ENT. These additions enhance Medtronic's capacity to provide a more comprehensive range of care for individuals coping with chronic rhinosinusitis (CRS), fortifying its foothold in the global healthcare technology market. Intersect ENT, a US-based medical device manufacturer, specializes in developing drug-delivery devices tailored for ear, nose, and throat (ENT) conditions.
Major companies operating in the bronchoscope market include Ambu A/S, Boston Scientific Corporation, Cogentix Medical Inc., Cook Medical LLC, Fujifilm Holdings Corporation, Hoya Corporation, Karl Storz Endoscopy SE & Co. KG, Olympus Corporation, PENTAX Medical, Richard Wolf GmbH, Teleflex Incorporated, EFER Endoscopy Srl, Lymol Medical Corporation, Schindler Endoskopie Technology GmbH, Scholly Fiberoptic GmbH, Uptake Medical B.V., Broncus Medical Inc., Novatech SA, Shanghai AoHua Photoelectricity Endoscope Co. Ltd., Rochling Group, Stryker Corporation, NeoScope Inc., Bryan Corporation, CONMED Corporation, Laborie Medical Technologies Corp., Envision Endoscopy Inc., SonoScape Medical Corp., Verathon Inc., Medtronic plc
North America was the largest region in the bronchoscope market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bronchoscope market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the bronchoscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bronchoscope market consists of sales of fiber optic bronchoscopes and video bronchoscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bronchoscope Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bronchoscope market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bronchoscope ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bronchoscope market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.